A cancer patient enrolled in a clinical trial today might wait months before regulators ever see the safety data generated by their treatment. The FDA wants to change that, and it has started running ...

GLP-1 telehealth evolution — how platforms survived the FDA crackdown on compounding, and what it means for patient access, ...

Marty Makary announced his resignation from the Food and Drug Administration after it was reported that President Donald Trump planned to fire him. News of Makary's resignation came a day before he ...

Recent FDA authorization for fruit-flavored vapes was a victory for harm reduction, but only happened with problematic ...